Predictive Role of the Age-Adjusted Charlson Comorbidity Index for Long-Term Survival of Surgical Esophageal Cancer Patients

Sakai M, Sohda M, Uchida S, Yamaguchi A, Watanabe T, Saito H, et al. Impact of the ratio of visceral fat area (VFA) to psoas muscle area (PMA) (V/P ratio) on survival for surgically resected esophageal cancer. Ann Surgl Oncol. 2022. https://doi.org/10.1093/dote/doac051.462.

Article  Google Scholar 

Song J, Lin Y, Zhang J, Liu S, Zhou J, Zeng Q, et al. Effect of the age-adjusted Charlson Comorbidity Index on the survival of esophageal squamous cell carcinoma patients after radical esophagectomy. J Clin Med. 2022;11:6737.

Article  PubMed  PubMed Central  Google Scholar 

Jiang W, Sun X, Zhou B, Han C, Liu F, Zheng J, Sun X. Evaluation of surgery plus postoperative radiotherapy or definitive radiotherapy in older patients with thoracic esophageal squamous cell cancer. J Cancer Res Ther. 2019;15:849–56.

Article  PubMed  Google Scholar 

Aoyama T, Atsumi Y, Kawahara S, Tamagawa H, Tamagawa A, Ozawa Y, et al. The clinical impact of the age-adjusted Charlson Comorbidity Index on esophageal cancer patients who receive curative treatment. In Vivo. 2020;34:2783–90.

Article  PubMed  PubMed Central  Google Scholar 

Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson Comorbidity Index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8–35.

Article  PubMed  Google Scholar 

Di Donato V, D’Oria O, Giannini A, Bogani G, Fischetti M, Santangelo G, et al. Age-adjusted Charlson Comorbidity Index predicts survival in endometrial cancer patients. Gynecol Obstet Invest. 2022;87:191–9.

Article  PubMed  Google Scholar 

Comments (0)

No login
gif